Kathryn White

Professor Cancer

University of Sydney
Country flagAustralia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kathryn White is a Professor of Cancer at the University of Sydney, Australia. Her research focuses on cancer survivorship, patient care pathways, and the development of educational interventions for healthcare professionals in oncology. Recent publications include studies on resilience in adults with cancer, interventions for improving communication with carers, and the impact of care models on patient outcomes. Professor White is dedicated to enhancing the quality of care for cancer patients through innovative research and evaluation.

Articles (18)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Introduction Radiation therapy (RT) can benefit approximately 50% of cancer patients and contribute to 40% of all cancer cures, yet its utilisation in cancer is low globally. Several factors contribute to this including perceived inconvenience related to accessing and utilising RT. To quantitatively assess the latter, a new tool – the Radiation therapy‐related Inconvenience Questionnaire (RIQ) – was developed. This study aimed to pre‐test the RIQ and explore barriers and facilitators to implementing it in routine clinical practice and clinical trials. Methods Semi‐structured cognitive interviews were conducted with patients undertaking RT, recruited via three hospitals to examine content validity, acceptability, and comprehensibility of the RIQ. Interviews identified inconsistencies, relevance, and clarity of items. Semi‐structured interviews with healthcare professionals involved in the delivery of care to individuals undertaking RT explored barriers and facilitators to routine usage. Thematic analysis was used to identify themes. Results Patients ( N = 15) identified problems in content, instructions, layout, length, and response options; consequently, 25 items were revised and eight removed, resulting in a final 29‐item questionnaire. Clinicians identified staff‐ and patient‐specific barriers to implementing RIQ in clinical practice. Perceived facilitators included the following: (a) workplace factors, (b) mode of administration, and (c) imparting knowledge. Conclusion This study demonstrated acceptability and comprehensibility of the 29‐item RIQ amongst cancer patients undertaking RT and treating clinicians. The next phase will evaluate the RIQ's measurement properties in a larger clinical study. The barriers and facilitators identified can guide future implementation of RIQ in clinical practice and clinical trials.

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (14)

Penelope Schofield

Swinburne University of Technology

AUSTRALIA
View details

Judy Kay

Professor

University of Sydney

AUSTRALIA
View details

Christobel Saunders

University of Western Australia

AUSTRALIA
View details

Ian Olver

Adjunct Professor

University of Adelaide

AUSTRALIA
View details

Marguerite Tracy

Senior lecturer

University of Sydney

AUSTRALIA
View details

Puma Sundaresan

-

AUSTRALIA
View details

Philip Beale

-

AUSTRALIA
View details

Claudia Rutherford

-

AUSTRALIA
View details

Ilse Mesters

Associate professor

-

NETHERLANDS
View details

Judy M Simpson

Professor of Biostatistics

The University of Sydney School of Public Health

AUSTRALIA
View details

Sheena Arora

University of Sydney

AUSTRALIA
View details

Janani Mahadeva

Associate Professor

Macquarie University

AUSTRALIA
View details

Catherine Leahy

Charles Sturt University

AUSTRALIA
View details

Bryan Anthony Chan

Associate Professor

Griffith University

AUSTRALIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.